From lab to clinic
A next‑generation consortium uniting TNO, LUMC, CHDR, and LACDR to accelerate breakthroughs in human health through integrated, translational skin science.
By combining advanced technology platforms with clinical and pharmacological expertise, we deliver high‑impact innovation in skin R&D, predictive model development, and targeted compound discovery. Thereby, LSI enables faster market access for personalized healthcare solutions and more effective strategies for disease prevention and management.
Our goal is to improve skin health and reduce the burden of skin diseases for European populations and globally. LSI takes a multi-disciplinary approach to skin research and innovation by linking scientists with clinicians. We are translating scientific and clinical excellence into knowledge and economic outcomes for the benefit of society.
Our research programs address key clinical questions ranging from personal health to personal care. In addition, we are also expanding our research and innovation efforts in advanced skin-permeability analyses, biomarker identification and host-microbiome interactions and systems health.
"We combine strengths and expertise to drive progress — from concept to validated approach, and from bench to bedside. Our mission: to improve human health through interdisciplinary research, scientific excellence, and real-world impact for you and society."
Upcoming events
No events were found in the selected period.
Solutions that work for you
We combine expertise and practical insight to deliver results you can rely on.